Parallel Learning Secures Major Funding to Tackle Special Education Challenges Across the United States
Parallel Learning, the New York‑based ed‑tech and teletherapy platform focused on delivering special education services, has continued to attract significant investor interest as it scales its operations nationwide. The company, founded in 2021 by CEO Diana Heldfond, offers virtual psychoeducational assessments, therapy, and ongoing support for students with learning and thinking differences. Its technology‑enabled approach aims to address chronic shortages of licensed specialists, reducing wait times for evaluations and services that many districts struggle to provide.
The most recent milestone for Parallel Learning came in December 2025, when it announced a $20 million Series B funding round led by Valspring Capital, a healthcare‑focused investment firm formed by former Bain Capital healthcare investors. This latest fundraising brings Parallel Learning’s total capital raised since inception to approximately $48.9 million, positioning the company for accelerated growth as well as further refinement and scaling of its clinical and technology offerings.
In addition to Valspring Capital, the Series B round saw participation from existing backers such as Rethink Impact, a venture capital firm with a track record of supporting mission‑driven founders. These investors helped fuel Parallel’s expansion from early operations into a broader, nationwide footprint.
Parallel’s outsize success in attracting capital underscores the growing recognition of the special education crisis in the United States. An increasing number of school districts face shortages of qualified professionals such as licensed speech‑language pathologists, psychologists, and special education instructors. Parallel Learning’s virtual platform pairs these licensed specialists with school partners and families using secure teletherapy tools and data‑driven progress monitoring. Its Pathway platform integrates clinical oversight, automated tracking of individualized goals, and real‑time support, helping students meet or exceed educational benchmarks.
Prior to the Series B, Parallel Learning had already made a strong impression on the investor community with its $20 million Series A funding round announced in 2022. That round was led by Tiger Global, a prominent global investment firm known for backing high‑growth technology companies. Joining Tiger Global in that initial institutional funding were Obvious Ventures, JAWS Ventures, the fund founded by real estate entrepreneur Barry Sternlicht, and Vine Ventures, which had led Parallel’s earliest seed financing efforts.
The Series A was a pivotal moment in Parallel’s trajectory. Coming just five months after the company’s official launch, it marked confidence from top‑tier venture firms in the potential of teletherapy and digital services to transform educational outcomes. Funds from the Series A were deployed toward expanding the company’s suite of clinical offerings, adding behavioral therapy and speech services alongside existing psychoeducational assessments, and scaling licensing and provider recruitment across states.
Parallel Learning’s earliest funding came from a $2.8 million seed round announced in December 2021, which launched the company’s journey. That seed round was led by Vine Ventures’ Eric Reiner and Dan Povitsky, with participation from Global Founders Capital, Great Oaks Venture Capital, and social media investor group Animal Capital, backed by influencers such as Josh Richards, Griffin Johnson, and Noah Beck. These early funds were used to build out the initial technology, hire clinical talent, and begin delivering services to families and school districts.
Across these funding milestones, Parallel Learning has demonstrated rapid growth. By late 2025, the company reported serving more than 10,000 students across 25 states, with plans to expand nationwide in the coming years. Outcomes data shared by the company highlighted that 98 % of students using its services met or exceeded their individualized education goals, reinforcing investor confidence in Parallel’s integrated clinical‑technology model.
As Parallel accelerates its mission, the influx of capital from leading venture firms signals broader momentum in the ed‑tech and digital health sectors, particularly solutions that tackle systemic challenges like access to specialized education and therapy services. With funding from both established and impact‑oriented investors, Parallel Learning appears well‑positioned to expand its clinical footprint, enhance its proprietary clinical‑technology platform, and continue reshaping how educational support is delivered to students with diverse learning needs nationwide.
